GC

Gastric Cancer

Gastric Cancer is a high-level global forum dedicated to all areas of research, treatment, and biology relevant to gastric cancer. It welcomes original articles, case reports, short communications, technical notes, and Letters to the Editor, while review articles are primarily solicited by the Editor.

Looking to publish in Gastric Cancer? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Impact Factor 5.1
Quartile Q1
Open Access Type Hybrid
ISSN 1436-3291
eISSN 1436-3305
Invitation Only No
Cost Range Open access APC: £3690.00 GBP / $5690.00 USD / €4390.00 EUR; subscription publishing: no APC charges apply.

Submission Instructions

Gastric Cancer accepts the following article types. Click on an article type to view submission instructions.

Original Articles

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required and must not exceed 250 words. Abstract must not exceed 250 words. Abstract must be structured into four paragraphs. Abstract headings must be Background, Methods, Results, and Conclusions.
Manuscript Manuscript must be up to 4000 words excluding references. Manuscript must include three to five MeSH keywords, a mini-abstract of no more than 30 words, a disclosure statement, and a Declarations section before the references.
References References must follow the U.S. National Library of Medicine style based on Index Medicus. References must be numbered consecutively in order of first mention and list the first six authors followed by et al.
Figures & Tables A maximum of seven figures and tables in total is permitted. Tables must each be placed on a separate page, and figure captions must be included in the manuscript text file rather than in the figure files. Tables and figures must be numbered consecutively in the order of first citation in the text.
Reformat to Gastric Cancer using Livewrite Premium

Review Articles

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not exceed 250 words.
Manuscript Review article text must be up to 5000 words excluding references. Review articles must include a disclosure statement, a contribution statement identifying who had the idea for the article, who performed the literature search and data analysis, and who drafted and/or critically revised the work, three to five MeSH keywords, a mini-abstract of no more than 30 words, and a Declarations section before the references.
References References must follow the U.S. National Library of Medicine style based on Index Medicus. References must be numbered consecutively in order of first mention, cited with Arabic numerals in square brackets, and list the first six authors followed by et al.
Figures & Tables Review articles may include no more than seven figures and tables in total. Figure captions must be included in the manuscript text file, while figures are supplied electronically and each table is typed on a separate page. Tables and figures must be numbered consecutively in the order of first citation, each table must have a brief title, and each figure must have a concise caption.
Reformat to Gastric Cancer using Livewrite Premium

Meta-Analysis Studies

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required. Abstract must not exceed 250 words.
Manuscript The manuscript must include three to five MeSH key words and a "Declarations" section before the references, and any use of a large language model must be documented in the Methods section or another suitable section.
References References must use the U.S. National Library of Medicine/Index Medicus style. References must be numbered consecutively in order of first mention, cited in square brackets, and list the first six authors followed by et al.
Figures & Tables Figures & Tables requirements are not specified.
Reformat to Gastric Cancer using Livewrite Premium

Case Reports

Cover Letter Cover Letter requirements are not specified.
Abstract Case Reports must include an abstract. The abstract must not exceed 150 words. The abstract must be unstructured.
Manuscript Case Reports must be up to 1500 words excluding references. The manuscript must include three to five MeSH key words and a 30-word mini-abstract for the table of contents.
References References must use the U.S. National Library of Medicine style based on Index Medicus. References must be numbered consecutively in order of first mention and list the first six authors followed by et al.
Figures & Tables Case Reports may include no more than seven figures and tables in total.
Reformat to Gastric Cancer using Livewrite Premium

Short Communications

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not exceed 250 words.
Manuscript Short Communications must be up to 1500 words excluding references. Manuscript must include three to five MeSH key words, a mini-abstract of no more than 30 words, a conflict of interest section, a Declarations section before the references, and documentation of large language model use in the Methods or a suitable alternative section if applicable.
References References must follow the U.S. National Library of Medicine style in Index Medicus. References must be numbered consecutively in order of first mention and list the first six authors followed by et al.
Figures & Tables Short Communications may include no more than four figures and tables in total. Tables must be on separate pages and figures must be supplied electronically with captions included in the manuscript text file.
Reformat to Gastric Cancer using Livewrite Premium

Letters To The Editor

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract requirements are not specified.
Manuscript Letters to the Editor must be no more than 500 words, excluding references.
References References must use the U.S. National Library of Medicine style in Index Medicus. References must be numbered consecutively in order of first mention and list the first six authors followed by et al.
Figures & Tables Letters to the Editor may not include any figures or tables.
Reformat to Gastric Cancer using Livewrite Premium

Recent Publications

Phase II study of mFOLFOX6 in advanced gastric cancer patients with severe peritoneal metastases (WJOG10517G), including an individual patient data comparison with JCOG1108/WJOG7312G

Toshiki Masuishi, Hiroki Hara, Takayuki Ando, Takeshi Kawakami, Yoshiyuki Yamamoto, Naotoshi Sugimoto, Kazuhiro Shiraishi, Taito Esaki, Yuji Negoro, Takao Tsuzuki, Hiroaki Sawai, Masato Nakamura, Takashi Inagaki, Yudai Shinohara, Kentaro Kawakami, Seiichiro Mitani, Kenji Tsuchihashi, Chihiro Kondoh, Hiroo Katsuya, Osamu Maeda, Yuriko Fujita, Kenichi Yoshimura, Masanori Terashima, Takako Eguchi Nakajima, Kei Muro

10.1007/s10120-026-01790-3
View Publication

Prognosis-predicting factor of gastrectomy after systemic cancer therapy for cStage IVB gastric cancer

Takumi Habu, Takahiro Kinoshita, Daiki Terajima, Izuma Nakayama, Masahiro Yura, Mitsumasa Yoshida, Naoya Sakamoto, Takeshi Kuwata, Kohei Shitara

10.1007/s10120-026-01795-y
View Publication

Correction: Hepatic origin of increased serum TFF3 in gastric cancer bearing subjects

Komei Kuge, Junko Mukohyama, Yoshimi Yasukawa, Yuko Ishibashi, Hiroki Masuda, Tomohiko Yasuda, Yasukazu Ohmoto, Hideyuki Takeshima, Akihisa Matsuda, Hiroshi Yoshida, Yasuyuki Seto, James R. Goldenring, Toshikazu Ushijima, Sachiyo Nomura

10.1007/s10120-026-01794-z
View Publication

Primary outcomes of a phase II trial of laparoscopic/robotic total gastrectomy with spleen-preserving splenic hilar dissection for locally advanced proximal gastric cancer involving the greater curvature (JCOG1809)

Takahiro Kinoshita, Masayuki Yokoyama, Junya Kitadani, Takeshi Omori, Souya Nunobe, Shinji Kuroda, Michitaka Honda, Haruhiko Cho, Masaki Aizawa, Yukinori Kurokawa, Tomoya Tsukada, Shusuke Haruta, Kazunari Misawa, Kazuhisa Ehara, Kota Kawabata, Masanori Terashima, Takaki Yoshikawa

10.1007/s10120-026-01792-1
View Publication

Mesenchymal R-spondin 3 promotes an immunogenic tumor microenvironment with adaptive immune resistance in human gastric adenocarcinoma

Anne-Sophie Fischer, Alexander Arnold, Hilmar Berger, Stefanie Müllerke, Jonas Wizenty, Hans-Joachim Mollenkopf, David Horst, Frank Tacke, Christoph Treese, Michael Sigal

10.1007/s10120-026-01791-2
View Publication

Frequently asked questions

How long does it take to publish?

Prospective randomized controlled trials must be registered within 6 months from first patient enrollment. Articles are published online after receipt of corrected proofs.

Reformat to Gastric Cancer using Livewrite Premium

Is a cover letter required?

A submission letter is referenced for reviewer suggestions and for transparency on reuse of material and unpublished material included in the manuscript.

Reformat to Gastric Cancer using Livewrite Premium

What are the publication costs?

Open access APC: £3690.00 GBP / $5690.00 USD / €4390.00 EUR. Subscription publishing has no APC charges.

Reformat to Gastric Cancer using Livewrite Premium

Research Topics

Gastric Cancer Management and Outcomes Helicobacter pylori-related gastroenterology studies Gastrointestinal Tumor Research and Treatment Esophageal Cancer Research and Treatment Metastasis and carcinoma case studies Colorectal Cancer Treatments and Studies Esophageal and GI Pathology Bariatric Surgery and Outcomes HER2/EGFR in Cancer Research Cancer Cells and Metastasis Cancer Immunotherapy and Biomarkers Genetic factors in colorectal cancer Cholangiocarcinoma and Gallbladder Cancer Studies Multiple and Secondary Primary Cancers Colorectal Cancer Screening and Detection Colorectal Cancer Surgical Treatments Gastrointestinal disorders and treatments Enhanced Recovery After Surgery Inflammatory Biomarkers in Disease Prognosis Intraperitoneal and Appendiceal Malignancies Nutrition and Health in Aging Ferroptosis and cancer prognosis Minimally Invasive Surgical Techniques Pancreatic and Hepatic Oncology Research Wnt/β-catenin signaling in development and cancer